Trends in pharmacological stimulation of regeneration of ionizing radiation-damaged mammalian organism

Česká verzia

Authors: Michal Hofer
Authors place of work: Biofyzikální ústav AV ČR, v. v. i., Brno
Published in the journal: Čas. Lék. čes. 2020; 159: 275-280
Category: Review Article

Summary

Many different substances with varying mechanisms of effects have been tested both in animal experiments, as well as verified in clinical studies as potential radioprotectors and mitigators of radiation damage. Among them, especially cytokines and hematopoietic growth factors have been used also for treatment of radiation accident victims. Two granulocyte colony-stimulating factor-based radiation countermeasures have been approved already for the treatment of the acute radiation syndrome. Nevertheless, a wide spectrum of other substances comprising, e.g., various immunomodulators, prostaglandins, inhibitors of prostaglandin synthesis, agonists of adenosine receptors, herbal extracts, flavonoids, vitamins, and others, has also been studied. These agents with various mechanisms of their influences on an organism are often effective, relatively non-toxic, and cheap. This review concentrates predominantly on the results of experiments which show the potential of untraditional or new radiation countermeasures to become a part of therapeutic procedures applicable in patients with the acute radiation syndrome.

Keywords:

acute radiation syndrome – radioprotectors – radiomitigators – Hematopoiesis

Zdroje

Pospíšil M, Šandula J, Pípalová I et al. Hemopoiesis stimulating and radioprotective effects of carboxymethylglucan. Physiol Res 1991; 40: 377–380.
Hérodin F, Roy L, Grenier N et al. Antiapoptotic cytokines in combination with pegfilgrastim soon after irradiation mitigate myelosuppression in nonhuman primates exposed to high radiation dose. Exp Hematol 2007; 35: 1172–1181.
Hirouchi T, Ito K, Nakano M et al. Mitigative effects of a combination of multiple pharmaceutical drugs on the survival of mice exposed to lethal ionizing radiation. Curr Pharm Biotechnol 2015; 17: 190–199.
Singh VK et al. Colony-stimulating factors for the treatment of the hematopoietic compartment of the acute radiation syndrome (H-ARS): a review. Cytokine 2015; 71: 22–37.
Wasserman TH, Brizel DM. The role of amifostine as a radioprotector. Oncology (Williston Park) 2001; 15: 1349–1354.
Hofer M, Pospíšil M. Glucan as stimulator of hematopoiesis in normal and gamma-irradiated mice. A survey of the authors’ own results. Int J Immunopharmacol 1997; 19: 607–609.
Hofer M, Pospíšil M. Modulation of animal and human hematopoiesis by β-glucans: a review. Molecules 2011; 16: 7969–7979.
Stickney DR, Dowding C, Garsd A et al. 5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression. Int Immunopharmacol 2006; 6: 1706–1713.
Stickney DR, Groothuis JR, Ahlem C et al. Preliminary clinical findings on Nemune as a potential treatment for acute radiation syndrome. J Radiol Prot 2010; 30: 687–698.
Ainsworth EJ, Hatch MH. Decreased X-ray mortality in endotoxin-treated mice. Radiat Res 1957; 9: 84–84.
Fedoročko P, Brezáni P. Radioprotection of mice by the bacterial extract Broncho-Vaxom – comparison of survival 5 inbred mouse strains. Int J Immunother 1992; 8: 185–190.
Madonna GS, Ledney GD, Elliot TB et al. Trehalose dimycolate enhances resistance to infection in neutropenic animals. Infect Immun 1989; 57: 2495–2501.
Crescenti EJV, Croci M, Medina VA et al. Radioprotective potential of a novel therapeutic formulation of oligoelements Se, Zn, Mn plus Lachesis muta venom. J Radiat Res 2009; 50: 537–544.
Crescenti EJV, Medina VA, Croci M et al. Radioprotection of sensitive rat tissues by oligoelements Se, Zn, Mn plus Lachesis muta venom. J Radiat Res 2011; 52: 557–567.
Liu W, Chen Q, Wu S et al. Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage. J Radiat Res 2015; 56: 278–286.
Li N, Shen X, Liu Y et al. Isolation, characterization, and radiation protection of Sipunculus nudus L. polysaccharide. Int J Biol Macromol 2016; 83: 288–296.
Hanson WR, Ainsworth EJ. 16,16-dimethyl prostaglandin E2 induces radioprotection in murine intestinal and hematopoietic stem-cells. Radiat Res 1985; 103: 196–203.
Kurland J, Moore MAS. Modulation of hemopoiesis by prostaglandins. Exp Hematol 1977; 7: 119–126.
Hofer M, Pospíšil M, Hoferová Z et al. Stimulatory action of cyclooxygenase inhibitors on hematopoiesis: a review. Molecules 2012; 17: 5615–5625.
Hofer M, Pospíšil M, Znojil V et al. Meloxicam, a cyclooxygenase-2 inhibitor, supports hematopoietic recovery in gamma-irradiated mice. Radiat Res 2006; 166: 556–560.
Hofer M, Pospíšil M, Dušek L et al. A single dose of an inhibitor of cyclooxygenase 2, meloxicam, administered shortly after irradiation increases survival of lethally irradiated mice. Radiat Res 2011; 176: 269–272.
Hoggatt J, Singh P, Stilger KN et al. Recovery from hematopoietic injury by modulating prostaglandin E₂ signaling post-irradiation. Blood Cells Mol Dis 2013; 50: 147–153.
Arora R, Gupta D, Chawla R et al. Radioprotection by plant products: present status and future prospects. Phytother Res 2005; 19: 1–22.
Weiss JF, Landauer MR. Radioprotection by antioxidants. Ann NY Acad Sci 1998; 899: 44–60.
Singh VK, Beattie LA, Seed TM. Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures. J Radiat Res 2013; 54: 973–988.
Singh VK, Hauer-Jensen M. Gamma-tocotrienol as a promising countermeasure for acute radiation syndrome: current status. Int J Mol Sci 2016; 17: 663.
Weiss JF, Srinivasan V, Kumar KS, Landauer MR. Radioprotection by metals: selenium. Adv Space Res 1992; 12: 223–231.
Weiss JF, Landauer MR. History and development of radiation-protective agents. Int J Radiat Biol 2009; 85: 539–573.
Landauer MR. Radioprotection by the soy isoflavone genistein. In: Arora R (ed.). Herbal Radiomodulators: Applications in Medicine, Homeland Defence and Space. Cabi, Wallingford, 2008: 163–173.
Pospíšil M, Hofer M, Znojil V et al. Radioprotection of mouse hemopoiesis by dipyridamole and adenosine monophosphate in fractionated treatment. Radiat Res 1995; 142: 16–22.
Hofer M, Pospíšil M, Weiterová L, Hoferová Z. The role of adenosine receptor agonists in regulation of hematopoiesis. Molecules 2011; 16: 675–585.
Ghosh SP, Perkins MW, Hieber K et al. Radiation protection by a new chemical entity, Ex-Rad™: efficacy and mechanisms. Radiat Res 2009; 171: 173–179.
Suman S, Datta K, Doiron K et al. Radioprotective effects of ON 01210.Na upon oral administration. J Radiat Res 2012; 53: 368–376.
Miller RC, Murley JS, Grdina DJ. Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs. Radiat Res 2014; 181: 464–470.
Burdelya LG, Krivokrysenko VI, Tallant TC et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 2008; 320: 226–230.
Zhang L, Sun W, Wang J et al. Mitigation effect of an FGF-2 peptide on acute gastrointestinal syndrome after high-dose ionizing radiation. Int J Radiat Oncol Biol Phys 2010; 77: 261–268.
Deng W, Kimura Y, Gududuru V et al. Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid. Radiat Res 2015; 183: 465–475.
Hofer M, Hoferová Z, Depeš D, Falk M. Combining pharmacological countermeasures to attenuate the acute radiation syndrome – a concise review. Molecules 2017; 22: 834.

Štítky

Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist

Článek Crucial moments in Czechoslovak radiobiology history

Článek Biological effects of ionizing radiation

Článek Modern trends in radiotherapy

Článek DNA repair in head and neck tumor cells and possibilities of its monitoring to estimate individual tumor radioresistance and selection of optimal primary treatment

Článek Úvodem

Článek Editorial

Článek Biological dosimetry and modern (-omic) methods

Článek Advances in research of DNA damage and repair in cells exposed to various types of ionizing radiation in the era of super-resolution optical microscopy

Článek Principles and new perspectives in the vaccination against SARS-CoV-2 virus

Článek Age is not a disease: Evolution of protective antibodies against SARS-CoV-2 in seniors from the Břevnice nursing home

Článek Season of the year, vitamin D and COVID-19

Článok vyšiel v časopise